
“In a fast-moving market like RNA and nucleic acid delivery, conversations matter as much as collaborations.”

Whether you’re here for insights, opportunities, or simply curiosity, we’re ready to connect.
Get in touch directly with Klara for technical or business related information. We can share more detailed scientific and technical information to help you assess whether our platform is relevant for your projects. This includes insight into performance data, formulation flexibility, and use cases. If you’re interested, we are happy to follow-up with a deeper discussion under a Confidential Disclosure Agreement (CDA) so you can safely share it within your organization.
Contact David for Information on partnership models, licensing opportunities, co-development frameworks, and collaboration pathways. We are happy to talk to understand your priorities and explore how our platform could create mutual value.
Write to media@adalidsciences.com for more information about our science, our role in the market, and our vision for the future of nucleic acid delivery. Or get in touch with any other inquiries. We will be happy to provide press kits, arrange interviews, or offer expert commentary.
In the meantime, check our download page for news updates, press kits, summary documents, photographs, logos, etc.
Not considering a collaboration right now? That’s perfectly fine. We value dialogue with peers, consultants, and researchers who—like us—are shaping the future of RNA delivery. Let’s share perspectives, exchange market insights, and explore the landscape together. Approach Klara or David or use our contact email, we are looking forward to talking with you.
Klara Grantz Saskova, CEO
Get in touch directly with Klara for technical or business related information. We can share more detailed scientific and technical information to help you assess whether our platform is relevant for your projects. This includes insight into performance data, formulation flexibility, and use cases. If you’re interested, we are happy to follow-up with a deeper discussion under a Confidential Disclosure Agreement (CDA) so you can safely share it within your organization.
David Schreib, CCO
Contact David for Information on partnership models, licensing opportunities, co-development frameworks, and collaboration pathways. We are happy to talk to understand your priorities and explore how our platform could create mutual value.
Media & Press
Write to media@adalidsciences.com for more information about our science, our role in the market, and our vision for the future of nucleic acid delivery. Or get in touch with any other inquiries. We will be happy to provide press kits, arrange interviews, or offer expert commentary.
In the meantime, check our download page for news updates, press kits, summary documents, photographs, logos, etc.
Just a Conversation
Not considering a collaboration right now? That’s perfectly fine. We value dialogue with peers, consultants, and researchers who—like us—are shaping the future of RNA delivery. Let’s share perspectives, exchange market insights, and explore the landscape together. Approach Klara or David or use our contact email, we are looking forward to talking with you.
We are looking forward to talking to you. In the meantime, you might be interested in our materials available for download.
DownloadsYou can also approach us right away using the form below. We will get back to you within a day.